Hong I. Wan
Corporate Officer/Principal at ALX ONCOLOGY HOLDINGS INC.
Profile
Hong I.
Wan is the founder of Tallac Therapeutics, Inc. He is currently a Scientific Advisor at LSV Capital Management LLC and a Consulting CSO at ALX Oncology Holdings, Inc. His former position was as a Director at Pfizer Inc. He holds a doctorate degree from the University of California, Berkeley.
Hong I. Wan active positions
Companies | Position | Start |
---|---|---|
ALX ONCOLOGY HOLDINGS INC. | Corporate Officer/Principal | 01/04/2015 |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Founder | - |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Consultant / Advisor | - |
Former positions of Hong I. Wan
Companies | Position | End |
---|---|---|
PFIZER, INC. | Director/Board Member | 01/03/2015 |
Training of Hong I. Wan
University of California, Berkeley | Doctorate Degree |
Harvard University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ALX ONCOLOGY HOLDINGS INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private companies | 2 |
---|---|
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Finance |
- Stock Market
- Insiders
- Hong I. Wan